Canada-based biotech startup Avro is developing skin patches to deliver drugs to patients who are unable to swallow or chew. It is based on a technology which uses a biopolymer as platform for passive transdermal drug delivery of small molecules and drugs. The patches act much like nicotine patches and can deliver a variety of drugs, including allergy medications.